Calcinosis Cutis: Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT)
Phase 3
Completed
- Conditions
- Calcinosis Cutis in Connective Tissue Disease
- Interventions
- Device: shock wave therapy with Modulith SLK (Storz)
- Registration Number
- NCT01683500
- Lead Sponsor
- University of Zurich
- Brief Summary
Patients with calcinosis cutis due to connective tissue disease get a shock wave therapy. The shock wave therapy will be done in 3 sessions with one week interval. The outcome parameters are: change in pain, size of the calcinosis, of possible ulcers and intake of painkillers.
* Trial with medical device
- Detailed Description
Patients with calcinosis cutis due to connective tissue disease get a shock wave therapy (medical device). The shock wave therapy will be done in 3 sessions with one week interval. The outcome parameters are: change in pain (questionnaire), size of the calcinosis (ultrasound and CT), new ulcers and intake of painkillers.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4
Inclusion Criteria
Not provided
Read More
Exclusion Criteria
Not provided
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description shock wave therapy shock wave therapy with Modulith SLK (Storz) intervention: shock wave therapy with Modulith SLK (Storz)
- Primary Outcome Measures
Name Time Method change in pain after 6 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Hospital Zurich, Division of Rheumatology
🇨ðŸ‡Zurich, ZH, Switzerland